The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Epimedium-Derived Phytoestrogen Flavonoids Exert Beneficial Effect on Preventing Bone Loss in Late Postmenopausal Women: A 24-Month Randomized, Double-Blind and Placebo-Controlled Trial
Abstract
Epimedium brevicornum maxim, a nonleguminous medicinal plant, has been found to be rich in phytoestrogen flavonoids. Results from a 24-month randomized double-blind placebo-controlled clinical trial showed that Epimedium-derived phytoestrogen flavonoids were able to exert beneficial effects on preventing bone loss in late postmenopausal women, without resulting in a detectable hyperplasia effect on the endometrium. Introduction: We performed a 24-mo randomized double-blind placebo-controlled clinical trial for evaluating the effect of the Epimedium-derived phytoestrogen flavonoids (EPFs) on BMD, bone turnover biochemical markers, serum estradiol, and endometrial thickness in postmenopausal women. Materials and Methods: One hundred healthy late postmenopausal women, with a natural menopausal history within 10 ∼18 yr and with a BMD T-score at the lumbar spine between −2 and −2.5 SD, were randomized into EPF treatment group (n = 50; a daily dose of 60 mg Icariin, 15 mg Daidzein, and 3 mg Genistein) or placebo control group (n = 50). All participants received 300 mg element calcium daily. BMD, bone turnover biochemical markers, serum estradiol, and endometrial thickness were measured at baseline and 12 and 24 mo after intervention. Results: Eighty-five participants completed the trial. The patterns of BMD changes were significantly different between the EPF treatment group and placebo control group by repeated-measures ANOVA (p = 0.045 for interaction between time and group at femoral neck; p = 0.006 for interaction between time and group at lumbar spine). BMD was found with a decreased tendency in the placebo control group at 12 (femoral neck: −1.4%, p = 0.104; lumbar spine: −1.7%, p = 0.019) and 24 mo (femoral neck: −1.8%, p = 0.048; lumbar spine: −2.4%, p = 0.002), whereas EPF treatment maintained BMD at 12 (femoral neck: 1.1%, p = 0.285; lumbar spine:1.0%, p = 0.158) and 24 mo (femoral neck: 1.6%, p = 0.148; lumbar spine: 1.3%, p = 0.091). The difference in lumbar spine between the two groups was significant at both 12 (p = 0.044) and 24 mo (p = 0.006), whereas the difference in the femoral neck was marginal at 12 mo (p = 0.061) and significant at 24 mo (p = 0.008). Levels of bone biochemical markers did not change in the placebo control group. In contrast, EPF intervention significantly decreased levels of deoxypyrdinoline at 12 (−43%, p = 0.000) and 24 mo (−39%, p = 0.000), except for osteocalcin at 12 (5.6%, p = 0.530) and 24 mo (10.7%, p = 0.267). A significant difference in deoxypyrdinoline between the two groups was found at both 12 (p = 0.000) and 24 mo (p = 0.001). Furthermore, neither serum estradiol nor endometrial thickness was found to be changed in either groups during the clinical trial. Conclusions: EPFs exert a beneficial effect on preventing bone loss in late postmenopausal women without resulting in a detectable hyperplasia effect on the endometrium.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Writing Group for the Women's Health Initiative Investigators (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.3.321 · Cited by 15,889
Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.
Simonet, W. S., Lacey, D. L., Dunstan, C. R., Kelley, M., Chang, M.-S., Lüthy, R., Nguyen, H. Q., Wooden, S., Bennett, L., Boone, T., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80209-3 · Cited by 5,130
A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function.
Anderson, D. M., Maraskovsky, E., Billingsley, W. L., Dougall, W. C., Tometsko, M. E., Roux, E. R., Teepe, M. C., DuBose, R. F., Cosman, D., & Galibert, L. (1997) · Nature · doi:10.1038/36593 · Cited by 2,290
Bioavailability and bioefficacy of polyphenols in humans. II. Review of 93 intervention studies
Williamson, G., & Manach, C. (2005) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/81.1.243s · Cited by 1,340
Osteoprotegerin Is a Receptor for the Cytotoxic Ligand TRAIL
Emery, J. G., McDonnell, P., Burke, M. B., Deen, K. C., Lyn, S., Silverman, C., Dul, E., Appelbaum, E. R., Eichman, C., DiPrinzio, R., et al. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.23.14363 · Cited by 1,184
Gebbie, A. (2002) · Journal of Family Planning and Reproductive Health Care · doi:10.1783/147118902101196685 · Cited by 1,176
LONG-TERM PREVENTION OF POSTMENOPAUSAL OSTEOPOROSIS BY ŒSTROGEN
Lindsay, R., Aitken, J. M., Anderson, L. B., Hart, D. M., Macdonald, E. B., & Clarke, A. C. (1976) · The Lancet · doi:10.1016/s0140-6736(76)92217-0 · Cited by 952
OUTCOME FOR INFANTS OF VERY LOW BIRTHWEIGHT: SURVEY OF WORLD LITERATURE
STEWART, A. (1981) · The Lancet · doi:10.1016/s0140-6736(81)92198-x · Cited by 830
Endovaginal Ultrasound to Exclude Endometrial Cancer and Other Endometrial Abnormalities
Smith-Bindman, R., Kerlikowske, K., Feldstein, V. A., Subak, L., Scheidler, J., Segal, M., Brand, R., & Grady, D. (1998) · JAMA · doi:10.1001/jama.280.17.1510 · Cited by 736
Isoflavone-rich soy protein isolate attenuates bone loss in the lumbar spine of perimenopausal women
Alekel, D. L., Germain, A. S., Peterson, C. T., Hanson, K. B., Stewart, J. W., & Toda, T. (2000) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/72.3.844 · Cited by 542
Ström, A., Hartman, J., Foster, J. S., Kietz, S., Wimalasena, J., & Gustafsson, J.-Å. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308319100 · Cited by 534
HUTCHINSON, T. (1979) · The Lancet · doi:10.1016/s0140-6736(79)90640-8 · Cited by 452
Kreijkamp-Kaspers, S., Kok, L., Grobbee, D. E., de Haan, E. H. F., Aleman, A., Lampe, J. W., & van der Schouw, Y. T. (2004) · JAMA · doi:10.1001/jama.292.1.65 · Cited by 438
Morabito, N., Crisafulli, A., Vergara, C., Gaudio, A., Lasco, A., Frisina, N., D'Anna, R., Corrado, F., Pizzoleo, M. A., Cincotta, M., et al. (2002) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2002.17.10.1904 · Cited by 432
The Minimum Effective Dose of Estrogen for Prevention of Postmenopausal Bone Loss
LINDSAY, R., HART, D. M., & CLARK, D. M. (1985) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-198502000-00016 · Cited by 393
Setchell, K. D., & Lydeking-Olsen, E. (2003) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/78.3.593s · Cited by 367
Reflections on the Discovery and Significance of Estrogen Receptor β
Koehler, K. F., Helguero, L. A., Haldosén, L.-A., Warner, M., & Gustafsson, J.-A. (2005) · Endocrine Reviews · doi:10.1210/er.2004-0027 · Cited by 360
Granberg, S., Wikland, M., Karlsson, B., Norström, A., & Friberg, L.-G. (1991) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(91)90622-x · Cited by 352
Atkinson, C., Compston, J. E., Day, N. E., Dowsett, M., & Bingham, S. A. (2004) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/79.2.326 · Cited by 281
Mei, J. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.11.5217 · Cited by 280
Hormone replacement therapy and risk of hip fracture: population based case-control study
Michaëlsson, K., Baron, J. A., Farahmand, B. Y., Johnell, O., Magnusson, C., Persson, P.-G., Persson, I., & Ljunghall, S. (1998) · BMJ · doi:10.1136/bmj.316.7148.1858 · Cited by 256
Somekawa, Y. (2001) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(00)01080-2 · Cited by 252
Ling, X., Aimin, L., Xihe, Z., Xiaoshu, C., & Cummings, S. R. (1996) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009024 · Cited by 213
Pharmaceutical Prospects of Phytoestrogens
USUI, T. (2006) · Endocrine Journal · doi:10.1507/endocrj.53.7 · Cited by 210
Kimmel, D. B., Recker, R. R., Gallagher, J. C., Vaswani, A. S., & Aloia, J. F. (1990) · Bone and Mineral · doi:10.1016/0169-6009(90)90061-j · Cited by 194
Soymilk or progesterone for prevention of bone loss: A 2 year randomized, placebo–controlled trial
Lydeking–Olsen, E., Beck-Jensen, J.-E., Setchell, K. D. R., & Holm–Jensen, T. (2004) · European Journal of Nutrition · doi:10.1007/s00394-004-0497-8 · Cited by 179
Scheiber, M. D., Liu, J. H., Subbiah, M. T. R., Rebar, R. W., & Setchell, K. D. R. (2001) · Menopause · doi:10.1097/00042192-200109000-00015 · Cited by 178
Blair, H. C., Jordan, S. E., Peterson, T. G., & Barnes, S. (1996) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(19960616)61:4<629::aid-jcb17>3.0.co;2-a · Cited by 168
Wu, J., Oka, J., Tabata, I., Higuchi, M., Toda, T., Fuku, N., Ezaki, J., Sugiyama, F., Uchiyama, S., Yamada, K., et al. (2006) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.060208 · Cited by 140
Chen, Q., Kaji, H., Iu, M.-F., Nomura, R., Sowa, H., Yamauchi, M., Tsukamoto, T., Sugimoto, T., & Chihara, K. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030470 · Cited by 136
Skeletal benefits of soy isoflavones: a review of the clinical trial and epidemiologic data
Messina, M. J., Ho, S. C., & Alekel, D. L. (2004) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/00075197-200411000-00010 · Cited by 134
Phytoestrogen genistein stimulates the production of osteoprotegerin by human trabecular osteoblasts
Viereck, V., Gründker, C., Blaschke, S., Siggelkow, H., Emons, G., & Hofbauer, L. C. (2002) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10087 · Cited by 125
Zhang, G., Qin, L., Hung, W. Y., Shi, Y., Leung, P., Yeung, H. Y., & Leung, K. (2006) · Bone · doi:10.1016/j.bone.2005.11.019 · Cited by 125
Self-citationChen, K. M., Ge, B. F., P, H., et al. (2005) · PubMed · Cited by 113
Beneficial effects of regular Tai Chi exercise on musculoskeletal system
Qin, L., Choy, W., Leung, K., Leung, P., Au, S.-K., Hung, W.-Y., Dambacher, M. A., & Chan, K.-M. (2005) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-004-0559-2 · Cited by 105
Self-citationGao, Y. H., & YAMAGUCHI, M. (1999) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.22.805 · Cited by 81
Yamaguchi, M., & Sugimoto, E. (2000) · Molecular and Cellular Biochemistry · doi:10.1023/a:1007199120295 · Cited by 80
Qin, L., Zhang, G., Hung, W.-Y., Shi, Y.-Y., Leung, K., Yeung, H.-Y., & Leung, P. (2005) · Journal of Bone and Mineral Metabolism · doi:10.1007/bf03026324 · Cited by 73
Self-citationChen, Y., Ho, S. C., Lam, S. S. H., Ho, S. S. S., & Woo, J. (2004) · Menopause The Journal of The North American Menopause Society · doi:10.1097/01.gme.0000094394.59028.46 · Cited by 71
Totta, P., Acconcia, F., Virgili, F., Cassidy, A., Weinberg, P. D., Rimbach, G. H., & Marino, M. (2005) · Journal of Nutrition · doi:10.1093/jn/135.11.2687 · Cited by 71
Tyrosine kinase inhibitor effects on avian osteoclastic acid transport
Williams, J. P., Jordan, S. E., Barnes, S., & Blair, H. C. (1998) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/68.6.1369s · Cited by 61
Estrogen replacement therapy: determinants of persistence with treatment
Pilon, D., Castilloux, A. M., & LeLorier, J. (2001) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(00)01104-2 · Cited by 56
Distribution of isoflavonoids in non-leguminous taxa – An update
Macková, Z., Koblovská, R., & Lapčı́k, O. (2006) · Phytochemistry · doi:10.1016/j.phytochem.2006.01.020 · Cited by 55
Genistein, a Soybean Isoflavone, Inhibits Inward Rectifier K+ Channels in Rat Osteoclasts.
Okamoto, F., Okabe, K., & Kajiya, H. (2001) · The Japanese Journal of Physiology · doi:10.2170/jjphysiol.51.501 · Cited by 45
Modulation of estrogen receptor-β isoforms by phytoestrogens in breast cancer cells
Cappelletti, V., Miodini, P., di Fronzo, G., & Daidone, M. G. (2006) · International Journal of Oncology · doi:10.3892/ijo.28.5.1185 · Cited by 37
A Review of Clinical Trials of Therapies for Osteoporosis Using Fracture as an End Point
Blank, R. D., & Bockman, R. S. (1999) · Journal of Clinical Densitometry · doi:10.1016/s1094-6950(06)60409-5 · Cited by 36
Bone Mass Throughout Life: Bone Growth and Involution
Cooper, C. C. (1990) · Springer eBooks · doi:10.1007/978-94-010-9580-8_1 · Cited by 8
Cited by
Advances in pathogenesis and therapeutic strategies for osteoporosis
Song, S., Guo, Y., Yang, Y., & Fu, D. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108168 · Cited by 476
Chemical markers for the quality control of herbal medicines: an overview
Li, S., Han, Q., Qiao, C., Song, J., Lung Cheng, C., & Xu, H. (2008) · Chinese Medicine · doi:10.1186/1749-8546-3-7 · Cited by 310
Metadata
- Authors
- Zhang, G., Qin, L., & Shi, Y.
- Venue
- Journal of Bone and Mineral Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-07-01
- Volume
- 22
- Issue
- 7
- Pages
- 1072-1079
- ISSN
- 0884-0431 (ISSN-L)
- 1523-4681
- OpenAlex
- W2002685309
- Cited by
- 255
- References
- 47
- FWCI
- 7.37
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.